Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Alliance Expecting 510(k) Clearance For Class II SUDs; Catheter PMA Is Shaky

This article was originally published in The Gray Sheet

Executive Summary

Alliance Medical's premarket approval application for reprocessing single-use ablation catheters is not approvable unless the firm obtains certain agreements with original equipment manufacturers (OEMs), FDA says.

You may also be interested in...



FDA Readying Validation Guidance In Anticipation Of MDUFMA SUD Deadline

The Medical Device User Fee & Modernization Act's effects on the bundling of multiple reprocessed single-use devices into one premarket submission will be among topics addressed in an upcoming guidance on validation data, according to FDA device center reps

Single-Use Device Reprocessor 510(k) Requirements Delayed Until Summer

FDA announced at the eleventh hour that it will extend by six months the deadline for active enforcement of premarket requirements for reprocessors of Class II single-use devices, giving the firms a Valentine's Day reprieve

Single-Use Device Reprocessor 510(k) Requirements Delayed Until Summer

FDA announced at the eleventh hour that it will extend by six months the deadline for active enforcement of premarket requirements for reprocessors of Class II single-use devices, giving the firms a Valentine's Day reprieve

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT015342

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel